Psoriatic Arthritis (PsA) Treatment Research Report 2019-2024
This
report presents a comprehensive overview, market shares and growth
opportunities of Psoriatic Arthritis (PsA) Treatment market by product type,
application, key companies and key regions.
This
study considers the Psoriatic Arthritis (PsA) Treatment value generated from
the sales of the following segments:
Segmentation
by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast
to 2024 in section 10.7.
Nonsteriodal
Anti-inflammatory Drugs
Disease
Modifying Antirheumatic Drugs
Segmentation
by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast
to 2024 in section 10.8.
Hospitals
Clinics
Others
This
report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7
and 8.
Americas
United
States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast
Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle
East & Africa
Egypt
South
Africa
Israel
Turkey
GCC
Countries
The
report also presents the market competition landscape and a corresponding
detailed analysis of the major vendor/manufacturers in the market. The key
manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Johnson
& Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers
Squibb
Eli
Lilly
Amgen
AstraZeneca
Celgene
In
addition, this report discusses the key drivers influencing market growth,
opportunities, the challenges and the risks faced by key players and the market
as a whole. It also analyzes key emerging trends and their impact on present
and future development.
Research
objectives
To
study and analyze the global Psoriatic Arthritis (PsA) Treatment market size by
key regions/countries, product type and application, history data from 2014 to
2018, and forecast to 2024.
To
understand the structure of Psoriatic Arthritis (PsA) Treatment market by
identifying its various subsegments.
Focuses
on the key global Psoriatic Arthritis (PsA) Treatment players, to define,
describe and analyze the value, market share, market competition landscape,
SWOT analysis and development plans in next few years.
To
analyze the Psoriatic Arthritis (PsA) Treatment with respect to individual
growth trends, future prospects, and their contribution to the total market.
To
share detailed information about the key factors influencing the growth of the
market (growth potential, opportunities, drivers, industry-specific challenges
and risks).
To
project the size of Psoriatic Arthritis (PsA) Treatment submarkets, with
respect to key regions (along with their respective key countries).
To
analyze competitive developments such as expansions, agreements, new product
launches and acquisitions in the market.
To
strategically profile the key players and comprehensively analyze their growth
strategies.
Table of Contents
2019-2024 Global Psoriatic Arthritis (PsA) Treatment
Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment
Market Size 2014-2024
2.1.2 Psoriatic Arthritis (PsA) Treatment Market
Size CAGR by Region
2.2 Psoriatic Arthritis (PsA) Treatment Segment by
Type
2.2.1 Nonsteriodal Anti-inflammatory Drugs
2.2.2 Disease Modifying Antirheumatic Drugs
2.2.3 Biologics
2.3 Psoriatic Arthritis (PsA) Treatment Market Size
by Type
2.3.1 Global Psoriatic Arthritis (PsA) Treatment
Market Size Market Share by Type (2014-2019)
2.3.2 Global Psoriatic Arthritis (PsA) Treatment
Market Size Growth Rate by Type (2014-2019)
2.4 Psoriatic Arthritis (PsA) Treatment Segment by
Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Psoriatic Arthritis (PsA) Treatment Market Size
by Application
2.5.1 Global Psoriatic Arthritis (PsA) Treatment
Market Size Market Share by Application (2014-2019)
2.5.2 Global Psoriatic Arthritis (PsA) Treatment
Market Size Growth Rate by Application (2014-2019)
3 Global Psoriatic Arthritis (PsA) Treatment by
Players
3.1 Global Psoriatic Arthritis (PsA) Treatment
Market Size Market Share by Players
3.1.1 Global Psoriatic Arthritis (PsA) Treatment
Market Size by Players (2017-2019)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment
Market Size Market Share by Players (2017-2019)
3.2 Global Psoriatic Arthritis (PsA) Treatment Key
Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10)
(2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Psoriatic Arthritis (PsA) Treatment by Regions
4.1 Psoriatic Arthritis (PsA) Treatment Market Size
by Regions
4.2 Americas Psoriatic Arthritis (PsA) Treatment
Market Size Growth
4.3 APAC Psoriatic Arthritis (PsA) Treatment Market
Size Growth
4.4 Europe Psoriatic Arthritis (PsA) Treatment
Market Size Growth
4.5 Middle East & Africa Psoriatic Arthritis
(PsA) Treatment Market Size Growth
5 Americas
5.1 Americas Psoriatic Arthritis (PsA) Treatment
Market Size by Countries
5.2 Americas Psoriatic Arthritis (PsA) Treatment
Market Size by Type
5.3 Americas Psoriatic Arthritis (PsA) Treatment
Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas
Countries
6 APAC
6.1 APAC Psoriatic Arthritis (PsA) Treatment Market
Size by Countries
6.2 APAC Psoriatic Arthritis (PsA) Treatment Market
Size by Type
6.3 APAC Psoriatic Arthritis (PsA) Treatment Market
Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Psoriatic Arthritis (PsA) Treatment by
Countries
7.2 Europe Psoriatic Arthritis (PsA) Treatment
Market Size by Type
7.3 Europe Psoriatic Arthritis (PsA) Treatment
Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Psoriatic Arthritis
(PsA) Treatment by Countries
8.2 Middle East & Africa Psoriatic Arthritis
(PsA) Treatment Market Size by Type
8.3 Middle East & Africa Psoriatic Arthritis
(PsA) Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and
Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Psoriatic Arthritis (PsA) Treatment Market
Forecast
10.1 Global Psoriatic Arthritis (PsA) Treatment
Market Size Forecast (2019-2024)
10.2 Global Psoriatic Arthritis (PsA) Treatment
Forecast by Regions
10.2.1 Global Psoriatic Arthritis (PsA) Treatment
Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Psoriatic Arthritis (PsA) Treatment
Forecast by Type
10.8 Global Psoriatic Arthritis (PsA) Treatment
Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Psoriatic Arthritis (PsA) Treatment Product
Offered
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment
Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Johnson & Johnson
11.2.1 Company Details
11.2.2 Psoriatic Arthritis (PsA) Treatment Product
Offered
11.2.3 Johnson & Johnson Psoriatic Arthritis
(PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
.…continued
CONTACT DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment